“…The first and regulatory enzyme of the KP, indoleamine 2,3‐dioxygenase (IDO) (EC 1.13.11.17), has been shown to be increased in several brain diseases such as AIDS dementia complex (Sardar and Reynolds, 1995; Smith et al, 2001; Burudi et al, 2002), viral brain infection (Heyes et al, 1992; Maloney et al, 2000), brain abscesses (Schroten et al, 2001), cerebral malaria (Hansen et al, 2000), Alzheimer's disease (Guillemin et al, 2003a), epilepsy (Nakano et al, 1992), and glioblastoma (Uyttenhove et al, 2003). IDO can be strongly induced by inflammatory cytokines such as interferon‐γ (IFN‐γ), and to a lesser extent by TNF‐α and IFN‐α (Heyes et al, 1997a; Pemberton et al, 1997).…”